These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11678605)

  • 1. Model reactions of Cr (VI) with DNA mediated by thiol species.
    Krepkiy D; Antholine WE; Myers C; Petering DH
    Mol Cell Biochem; 2001 Jun; 222(1-2):213-9. PubMed ID: 11678605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.
    Quievryn G; Goulart M; Messer J; Zhitkovich A
    Mol Cell Biochem; 2001 Jun; 222(1-2):107-18. PubMed ID: 11678591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of chromium(VI) by thiols results in chromium(V) formation, chromium binding to DNA and altered DNA conformation.
    Borges KM; Boswell JS; Liebross RH; Wetterhahn KE
    Carcinogenesis; 1991 Apr; 12(4):551-61. PubMed ID: 1849467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadmium and lead interactions with transcription factor IIIA from Xenopus laevis: a model for zinc finger protein reactions with toxic metal ions and metallothionein.
    Petering DH; Huang M; Moteki S; Shaw CF
    Mar Environ Res; 2000; 50(1-5):89-92. PubMed ID: 11460756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group.
    Zhitkovich A; Voitkun V; Costa M
    Biochemistry; 1996 Jun; 35(22):7275-82. PubMed ID: 8679557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
    Zhitkovich A; Shrager S; Messer J
    Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells.
    Morse JL; Luczak MW; Zhitkovich A
    Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
    Zhitkovich A; Quievryn G; Messer J; Motylevich Z
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione.
    Kortenkamp A; Casadevall M; Faux SP; Jenner A; Shayer RO; Woodbridge N; O'Brien P
    Arch Biochem Biophys; 1996 May; 329(2):199-207. PubMed ID: 8638952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols.
    Levina A; Zhang L; Lay PA
    J Am Chem Soc; 2010 Jun; 132(25):8720-31. PubMed ID: 20527748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium (VI)-induced transformation is enhanced by Zn deficiency in BALB/c 3T3 cells.
    Kimura T; Onodera A; Okumura F; Nakanishi T; Itoh N
    J Toxicol Sci; 2015 Jun; 40(3):383-7. PubMed ID: 25972198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
    Quievryn G; Messer J; Zhitkovich A
    Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromium (VI) inhibits mouse metallothionein-I gene transcription by modifying the transcription potential of the co-activator p300.
    Kimura T; Okumura F; Onodera A; Nakanishi T; Itoh N; Isobe M
    J Toxicol Sci; 2011 Apr; 36(2):173-80. PubMed ID: 21467744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
    Guttmann D; Poage G; Johnston T; Zhitkovich A
    Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structures of chromium(VI) complexes with glutathione and model thiols.
    Levina A; Lay PA
    Inorg Chem; 2004 Jan; 43(1):324-35. PubMed ID: 14704084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of DNA-protein cross-linking by chromium.
    Macfie A; Hagan E; Zhitkovich A
    Chem Res Toxicol; 2010 Feb; 23(2):341-7. PubMed ID: 19877617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest.
    O'Brien T; Xu J; Patierno SR
    Mol Cell Biochem; 2001 Jun; 222(1-2):173-82. PubMed ID: 11678599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding of chromium(VI) and chromium(III) complexes to salmon sperm nuclei and nuclear DNA and isolated calf thymus DNA.
    Hneihen AS; Standeven AM; Wetterhahn KE
    Carcinogenesis; 1993 Sep; 14(9):1795-803. PubMed ID: 8403202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.
    Standeven AM; Wetterhahn KE
    Carcinogenesis; 1992 Aug; 13(8):1319-24. PubMed ID: 1499083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.